Login

Delisting Not on the Agenda" | Francis Van Eeckhout (Deceuninck) | CEO Talk | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Optimistic Outlook and Diversification Strategies | Paolo Gallo, CEO, Italgas SpA.
00:10:00
Globant's CEO Martin Migoya discusses their new augmented coding concept, set to be unveiled despite the pandemic.
00:00:00
Gianrico Farrugia, M.D. Gastroenterologist, Mayo Clinic
00:10:00
Lithium Universe Limited: Refining Strategy and Industry Challenges in North America.
00:10:00
A Message from Air Canada President and CEO, Calin Rovinescu | Calin Rovinescu, CEO, Air Canada.
00:10:00
invest in should be making a positive difference in the world|Matt Harris, Partner, Bain Capital Ventures
00:10:00
Decades-Long Sustainable Energy Journey: From Coal to Net Zero |Somruedee Chaimongkol, CEO, Banpu Public Company.
00:00:00
Emerging class of drugs for the treatment of chronic and age-related diseases - JOSEPH J. SARRET, M.D., J.D. Chief Executive Officer and Director, CohBar Inc
00:10:00
GCo and TTI: Integrated Operations and Market Insights
00:10:00
Maha Energy is interviewed by Erik Penser Bank on May 23, 2022, discussing the company's performance and future outlook.
00:10:00
Disrupting Legacy Systems: The Wise Approach to Global Payments | Kristo Käärmann ,CEO , Wise Plc.
00:10:00
Energy Transition: Government Investment and Mining Strategies

© 2017 - Neuhu+